Latest News & Updates

Breaking News

  • 7 hours ago

  • Vaibhavi M.

Nxera Partner Wins Taiwan Approval For QUVIVIQ Insomnia Treatment, Expanding Nxera’s Presence in Asian Markets
Breaking News
Avantor Expands India Portfolio With Exclusive Parafilm M Distribution Deal

Vaibhavi M.

Other trending news you may like to read

Nxera Partner Wins Taiwan Approval For QUVIVIQ Insomnia Treatment, Expanding Nxera’s Presence in Asian Markets

Nxera Pharma secures Taiwan approval for QUVIVIQ insomnia drug via partner Holling Bio-Pharma, enabling 2026 launch and expanding access across Asian markets.

Vaibhavi M.

Pharma Now

Avantor Expands India Portfolio With Exclusive Parafilm M Distribution Deal

Avantor, Inc. secures exclusive distribution of Parafilm M in India from Amcor, expanding access to lab sealing solutions for contamination prevention and sample protection.

Vaibhavi M.

Pharma Now

Praxis Advances Ulixacaltamide With FDA Review For Essential Tremor Treatment

Praxis Precision Medicines secures FDA NDA acceptance for ulixacaltamide to treat essential tremor, with Phase 3 data supporting efficacy and PDUFA decision set for January 2027.

Vaibhavi M.

Pharma Now

Amneal Expands Respiratory Portfolio With Launch Of Generic Albuterol and Beclomethasone Products

Amneal Pharmaceuticals launches generic albuterol and beclomethasone inhalers in the U.S. for asthma and bronchospasm, expanding its respiratory portfolio with complex MDI products.

Vaibhavi M.

Pharma Now